Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 839 (ZNF839) is a human protein encoded by the ZNF839 gene located on chromosome 14q32.31[3]. It belongs to the C2H2-type zinc finger transcription factor family, the largest family of transcription factors in the human genome[1][3]. ZNF839 contains a zinc finger domain and potentially a domain of unknown function (DUF4764)[2][5]. Predominantly expressed in the testis and certain regions of the brain, its main molecular role is transcription regulation through sequence-specific DNA binding, modulating target gene expression[3][2]. There is interest in ZNF839 as it has been identified as a renal carcinoma antigen (NY-REN-50)—suggesting overexpression in certain cancers and a possible immune or diagnostic role in oncology, but there are no known therapeutics targeting it or approved biomarker uses[3]. ZNF839 has been shown to interact with proteins such as TP53 and 14-3-3 proteins, supporting possible regulatory roles in the cell cycle, apoptosis, or DNA damage response, but its direct disease mechanisms and druggability remain poorly characterized[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 839 (ZNF839).